Zymeworks (ZYME) Non-Current Assets (2021 - 2026)

Zymeworks' (ZYME) quarterly Non-Current Assets came in at $92.5 million in Q1 2026, down 22.28% year-on-year from $119.1 million in Q1 2025, and down 5.34% quarter-over-quarter from $97.8 million in Q4 2025.

Zymeworks (ZYME) Non-Current Assets (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Non-Current Assets across 6 years of filings, most recently posting $92.5 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $92.5 million, down 22.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $408.1 million (down 26.76% YoY), and the FY2025 annual result was $97.8 million, down 39.89% from the prior year.
  • Non-Current Assets came in at $92.5 million for Q1 2026 at Zymeworks, down from $97.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $181.7 million in Q3 2023 to a low of $92.5 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $132.1 million (2024), against an average of $136.3 million.
  • Across the five-year window, Non-Current Assets surged 65.8% in 2023 and sank 39.89% in 2025, its largest moves.
  • Zymeworks' Non-Current Assets stood at $104.0 million in 2022, then jumped by 61.46% to $168.0 million in 2023, then dropped by 3.16% to $162.6 million in 2024, then tumbled by 39.89% to $97.8 million in 2025, then slipped by 5.34% to $92.5 million in 2026.
  • The last three Non-Current Assets figures came in at $92.5 million (Q1 2026), $97.8 million (Q4 2025), and $105.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - 92.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 92.54 Mn
Dec 31, 2025 97.76 Mn
Sep 30, 2025 105.56 Mn
Jun 30, 2025 112.26 Mn
Mar 31, 2025 119.06 Mn
Dec 31, 2024 162.64 Mn
Sep 30, 2024 143.38 Mn
Jun 30, 2024 132.14 Mn
Mar 31, 2024 159.93 Mn
Dec 31, 2023 167.95 Mn
Sep 30, 2023 181.73 Mn
Jun 30, 2023 181.72 Mn
Mar 31, 2023 174.37 Mn
Dec 31, 2022 104.02 Mn
Sep 30, 2022 109.61 Mn
Dec 31, 2021 100.91 Mn